[1]
Cunningham AL, Stephens JW, Harris DA. A review on gut microbiota: a central factor in the pathophysiology of obesity. Lipids in health and disease. 2021 Jul 7:20(1):65. doi: 10.1186/s12944-021-01491-z. Epub 2021 Jul 7
[PubMed PMID: 34233682]
[2]
Mulders RJ, de Git KCG, Schéle E, Dickson SL, Sanz Y, Adan RAH. Microbiota in obesity: interactions with enteroendocrine, immune and central nervous systems. Obesity reviews : an official journal of the International Association for the Study of Obesity. 2018 Apr:19(4):435-451. doi: 10.1111/obr.12661. Epub 2018 Jan 23
[PubMed PMID: 29363272]
[4]
Conlon MA, Bird AR. The impact of diet and lifestyle on gut microbiota and human health. Nutrients. 2014 Dec 24:7(1):17-44. doi: 10.3390/nu7010017. Epub 2014 Dec 24
[PubMed PMID: 25545101]
[5]
Pereira MA, Kartashov AI, Ebbeling CB, Van Horn L, Slattery ML, Jacobs DR Jr, Ludwig DS. Fast-food habits, weight gain, and insulin resistance (the CARDIA study): 15-year prospective analysis. Lancet (London, England). 2005 Jan 1-7:365(9453):36-42
[PubMed PMID: 15639678]
[6]
Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature. 2007 Oct 18:449(7164):804-10
[PubMed PMID: 17943116]
[7]
Shen J, Obin MS, Zhao L. The gut microbiota, obesity and insulin resistance. Molecular aspects of medicine. 2013 Feb:34(1):39-58. doi: 10.1016/j.mam.2012.11.001. Epub 2012 Nov 16
[PubMed PMID: 23159341]
[8]
Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, Egholm M, Henrissat B, Heath AC, Knight R, Gordon JI. A core gut microbiome in obese and lean twins. Nature. 2009 Jan 22:457(7228):480-4. doi: 10.1038/nature07540. Epub 2008 Nov 30
[PubMed PMID: 19043404]
[9]
Bruce-Keller AJ, Salbaum JM, Luo M, Blanchard E 4th, Taylor CM, Welsh DA, Berthoud HR. Obese-type gut microbiota induce neurobehavioral changes in the absence of obesity. Biological psychiatry. 2015 Apr 1:77(7):607-15. doi: 10.1016/j.biopsych.2014.07.012. Epub 2014 Jul 18
[PubMed PMID: 25173628]
[10]
Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006 Dec 21:444(7122):1022-3
[PubMed PMID: 17183309]
[11]
Million M, Thuny F, Angelakis E, Casalta JP, Giorgi R, Habib G, Raoult D. Lactobacillus reuteri and Escherichia coli in the human gut microbiota may predict weight gain associated with vancomycin treatment. Nutrition & diabetes. 2013 Sep 9:3(9):e87. doi: 10.1038/nutd.2013.28. Epub 2013 Sep 9
[PubMed PMID: 24018615]
[12]
Everard A, Lazarevic V, Gaïa N, Johansson M, Ståhlman M, Backhed F, Delzenne NM, Schrenzel J, François P, Cani PD. Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity. The ISME journal. 2014 Oct:8(10):2116-30. doi: 10.1038/ismej.2014.45. Epub 2014 Apr 3
[PubMed PMID: 24694712]
[13]
Shin NR, Lee JC, Lee HY, Kim MS, Whon TW, Lee MS, Bae JW. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut. 2014 May:63(5):727-35. doi: 10.1136/gutjnl-2012-303839. Epub 2013 Jun 26
[PubMed PMID: 23804561]
[14]
Vallianou N, Stratigou T, Christodoulatos GS, Dalamaga M. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives. Current obesity reports. 2019 Sep:8(3):317-332. doi: 10.1007/s13679-019-00352-2. Epub
[PubMed PMID: 31175629]
Level 3 (low-level) evidence
[15]
Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM, Muccioli GG, Delzenne NM. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. 2009 Aug:58(8):1091-103. doi: 10.1136/gut.2008.165886. Epub 2009 Feb 24
[PubMed PMID: 19240062]
[16]
Hartmann P, Chen P, Wang HJ, Wang L, McCole DF, Brandl K, Stärkel P, Belzer C, Hellerbrand C, Tsukamoto H, Ho SB, Schnabl B. Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice. Hepatology (Baltimore, Md.). 2013 Jul:58(1):108-19. doi: 10.1002/hep.26321. Epub 2013 May 27
[PubMed PMID: 23408358]
[17]
Wang J, Tang H, Zhang C, Zhao Y, Derrien M, Rocher E, van-Hylckama Vlieg JE, Strissel K, Zhao L, Obin M, Shen J. Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. The ISME journal. 2015 Jan:9(1):1-15. doi: 10.1038/ismej.2014.99. Epub 2014 Jun 17
[PubMed PMID: 24936764]
[18]
Roy CC, Kien CL, Bouthillier L, Levy E. Short-chain fatty acids: ready for prime time? Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition. 2006 Aug:21(4):351-66
[PubMed PMID: 16870803]
[19]
Willemsen LE, Koetsier MA, van Deventer SJ, van Tol EA. Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts. Gut. 2003 Oct:52(10):1442-7
[PubMed PMID: 12970137]
[20]
Singh RK, Chang HW, Yan D, Lee KM, Ucmak D, Wong K, Abrouk M, Farahnik B, Nakamura M, Zhu TH, Bhutani T, Liao W. Influence of diet on the gut microbiome and implications for human health. Journal of translational medicine. 2017 Apr 8:15(1):73. doi: 10.1186/s12967-017-1175-y. Epub 2017 Apr 8
[PubMed PMID: 28388917]
[21]
Sohail MU, Althani A, Anwar H, Rizzi R, Marei HE. Role of the Gastrointestinal Tract Microbiome in the Pathophysiology of Diabetes Mellitus. Journal of diabetes research. 2017:2017():9631435. doi: 10.1155/2017/9631435. Epub 2017 Sep 26
[PubMed PMID: 29082264]
[22]
Sanz Y, Moya-Pérez A. Microbiota, inflammation and obesity. Advances in experimental medicine and biology. 2014:817():291-317. doi: 10.1007/978-1-4939-0897-4_14. Epub
[PubMed PMID: 24997040]
Level 3 (low-level) evidence
[23]
Muccioli GG, Naslain D, Bäckhed F, Reigstad CS, Lambert DM, Delzenne NM, Cani PD. The endocannabinoid system links gut microbiota to adipogenesis. Molecular systems biology. 2010 Jul:6():392. doi: 10.1038/msb.2010.46. Epub
[PubMed PMID: 20664638]
[24]
Kelly D, King T, Aminov R. Importance of microbial colonization of the gut in early life to the development of immunity. Mutation research. 2007 Sep 1:622(1-2):58-69
[PubMed PMID: 17612575]
[25]
Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, Wagendorp AA, Klijn N, Bindels JG, Welling GW. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. Journal of pediatric gastroenterology and nutrition. 2000 Jan:30(1):61-7
[PubMed PMID: 10630441]
[26]
Coppa GV, Zampini L, Galeazzi T, Gabrielli O. Prebiotics in human milk: a review. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2006 Dec:38 Suppl 2():S291-4
[PubMed PMID: 17259094]
[27]
Arslanoglu S, Moro GE, Schmitt J, Tandoi L, Rizzardi S, Boehm G. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. The Journal of nutrition. 2008 Jun:138(6):1091-5
[PubMed PMID: 18492839]
[28]
Delzenne NM, Cani PD. Interaction between obesity and the gut microbiota: relevance in nutrition. Annual review of nutrition. 2011 Aug 21:31():15-31. doi: 10.1146/annurev-nutr-072610-145146. Epub
[PubMed PMID: 21568707]
[29]
Schroeder BO, Bäckhed F. Signals from the gut microbiota to distant organs in physiology and disease. Nature medicine. 2016 Oct:22(10):1079-1089. doi: 10.1038/nm.4185. Epub 2016 Oct 6
[PubMed PMID: 27711063]
[30]
Balakumar M, Prabhu D, Sathishkumar C, Prabu P, Rokana N, Kumar R, Raghavan S, Soundarajan A, Grover S, Batish VK, Mohan V, Balasubramanyam M. Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice. European journal of nutrition. 2018 Feb:57(1):279-295. doi: 10.1007/s00394-016-1317-7. Epub 2016 Oct 18
[PubMed PMID: 27757592]
[31]
Torres-Fuentes C, Schellekens H, Dinan TG, Cryan JF. The microbiota-gut-brain axis in obesity. The lancet. Gastroenterology & hepatology. 2017 Oct:2(10):747-756. doi: 10.1016/S2468-1253(17)30147-4. Epub 2017 Aug 24
[PubMed PMID: 28844808]
[32]
Morris DL, Rui L. Recent advances in understanding leptin signaling and leptin resistance. American journal of physiology. Endocrinology and metabolism. 2009 Dec:297(6):E1247-59. doi: 10.1152/ajpendo.00274.2009. Epub 2009 Sep 1
[PubMed PMID: 19724019]
Level 3 (low-level) evidence
[33]
de Lartigue G, Barbier de la Serre C, Espero E, Lee J, Raybould HE. Diet-induced obesity leads to the development of leptin resistance in vagal afferent neurons. American journal of physiology. Endocrinology and metabolism. 2011 Jul:301(1):E187-95. doi: 10.1152/ajpendo.00056.2011. Epub 2011 Apr 26
[PubMed PMID: 21521717]
[34]
Woodworth MH, Neish EM, Miller NS, Dhere T, Burd EM, Carpentieri C, Sitchenko KL, Kraft CS. Laboratory Testing of Donors and Stool Samples for Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection. Journal of clinical microbiology. 2017 Apr:55(4):1002-1010. doi: 10.1128/JCM.02327-16. Epub 2017 Jan 11
[PubMed PMID: 28077694]
[35]
Lau JT, Whelan FJ, Herath I, Lee CH, Collins SM, Bercik P, Surette MG. Capturing the diversity of the human gut microbiota through culture-enriched molecular profiling. Genome medicine. 2016 Jul 1:8(1):72. doi: 10.1186/s13073-016-0327-7. Epub 2016 Jul 1
[PubMed PMID: 27363992]
[36]
Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, Diakogiannaki E, Cameron J, Grosse J, Reimann F, Gribble FM. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes. 2012 Feb:61(2):364-71. doi: 10.2337/db11-1019. Epub 2011 Dec 21
[PubMed PMID: 22190648]
[37]
Chambers ES, Viardot A, Psichas A, Morrison DJ, Murphy KG, Zac-Varghese SE, MacDougall K, Preston T, Tedford C, Finlayson GS, Blundell JE, Bell JD, Thomas EL, Mt-Isa S, Ashby D, Gibson GR, Kolida S, Dhillo WS, Bloom SR, Morley W, Clegg S, Frost G. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut. 2015 Nov:64(11):1744-54. doi: 10.1136/gutjnl-2014-307913. Epub 2014 Dec 10
[PubMed PMID: 25500202]
[40]
Sun L, Ma L, Ma Y, Zhang F, Zhao C, Nie Y. Insights into the role of gut microbiota in obesity: pathogenesis, mechanisms, and therapeutic perspectives. Protein & cell. 2018 May:9(5):397-403. doi: 10.1007/s13238-018-0546-3. Epub
[PubMed PMID: 29725936]
Level 3 (low-level) evidence
[42]
Boursier J,Mueller O,Barret M,Machado M,Fizanne L,Araujo-Perez F,Guy CD,Seed PC,Rawls JF,David LA,Hunault G,Oberti F,Calès P,Diehl AM, The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology (Baltimore, Md.). 2016 Mar;
[PubMed PMID: 26600078]
[43]
Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI. The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences of the United States of America. 2004 Nov 2:101(44):15718-23
[PubMed PMID: 15505215]
[44]
Nova E, Pérez de Heredia F, Gómez-Martínez S, Marcos A. The Role of Probiotics on the Microbiota: Effect on Obesity. Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition. 2016 Jun:31(3):387-400. doi: 10.1177/0884533615620350. Epub 2016 Feb 11
[PubMed PMID: 26869611]
[45]
Drissi F, Raoult D, Merhej V. Metabolic role of lactobacilli in weight modification in humans and animals. Microbial pathogenesis. 2017 May:106():182-194. doi: 10.1016/j.micpath.2016.03.006. Epub 2016 Mar 23
[PubMed PMID: 27033001]
Level 3 (low-level) evidence
[46]
Lam YY,Ha CW,Hoffmann JM,Oscarsson J,Dinudom A,Mather TJ,Cook DI,Hunt NH,Caterson ID,Holmes AJ,Storlien LH, Effects of dietary fat profile on gut permeability and microbiota and their relationships with metabolic changes in mice. Obesity (Silver Spring, Md.). 2015 Jul;
[PubMed PMID: 26053244]
[47]
Lee P, Yacyshyn BR, Yacyshyn MB. Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT). Diabetes, obesity & metabolism. 2019 Mar:21(3):479-490. doi: 10.1111/dom.13561. Epub 2018 Nov 20
[PubMed PMID: 30328245]
[48]
Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, Woodward M. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. International journal of cancer. 2009 Jul 1:125(1):171-80. doi: 10.1002/ijc.24343. Epub
[PubMed PMID: 19350627]
Level 2 (mid-level) evidence